AG
BSX icon

Advocate Group’s Boston Scientific BSX Stock Holding History

Advocate Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,274
Closed -$205K – 126
2026
Q1 		$205K Hold
3,274
– – 0.03% 126
2025
Q4 		$312K Hold
3,274
– – 0.05% 104
2025
Q3 		$320K Hold
3,274
– – 0.05% 103
2025
Q2 		$352K Hold
3,274
– – 0.06% 98
2025
Q1 		$330K Hold
3,274
– – 0.06% 98
2024
Q4 		$292K Hold
3,274
– – 0.06% 102
2024
Q3 		$274K Hold
3,274
– – 0.05% 104
2024
Q2 		$252K Hold
3,274
– – 0.05% 108
2024
Q1 		$224K Buy
+3,274
New +$211K 0.04% 110

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Advocate Group's BSX Position: Q2 2026 in Review

Advocate Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,274 shares — an estimated $205K sold.

Advocate Group first reported a position in BSX in Q1 2024 and held it in 9 quarters. The position peaked at $352K in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Advocate Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Advocate Group sold 3,274 Boston Scientific shares in Q2 2026, an estimated $205K.
  • Advocate Group first reported a position in Boston Scientific in Q1 2024 and held it in 9 quarters.
  • Advocate Group's Boston Scientific position peaked at $352K in Q2 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.